Zentek Ltd.

NASDAQ:ZTEK

Other Precious Metals

Basic Materials
$0.49 +25.56%

+$0.10 today

Market cap
$62.30M
Beta
0.47
P/E (TTM)
-9.6
EPS (TTM)
-$0.08
52W Low $0.37High $1.34

Volume 0.93M

Average 0.15M

ZTEK Stock-Based Compensation

Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.

Zentek Ltd.NASDAQ: ZTEK

Stock-Based Compensation · Q4 FY2025 · quarter ended Mar 2026

Stock-based compensation outflow shrinks to CA$0

Q4 FY2025 stock-based compensation was CA$0, compared with CA$279.68K a year earlier. Trailing-twelve-month stock-based compensation was CA$190.87K.

Context

  • Stock-based compensation amounted to 0.0% of revenue in FY2025, down 175.4 pp from a year earlier.
  • Stock-based compensation increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly stock-based compensation holds near CA$0 or moves back toward the trailing-twelve-month quarterly average of CA$47.72K.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
CA$0— QoQ
Last fiscal yearMar 2026
CA$0-100.0% YoY
LTMMar 2026
CA$190.87K-64.5% YoY
Stock-Based Compensation past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-100.0%——
1 year-100.0%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Stock-Based Compensation history

CAD · from the cash flow

Latest · FY2025
0 CAD
Year-over-year change
-100.0%

Stock-Based Compensation vs competitors

How ZTEK compares with its peers on the latest reported figures

  • Peers report in different currencies, so stock-based compensation is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -64.5% is the lowest of 8, against a peer median of -41.5%.
  • Stock-based compensation amounts to 114.9% of revenue for ZTEK, versus a peer median of 11.7%.
ZTEK Competitors
Stock-Based Compensation for ZTEK and competitors
Company Period LTM YoY 3-year CAGR% of revenue
AMWLAmerican Well CorporationLTM Mar 2026$16.98M USD-56.1%-31.2%7.2%
CRDLCardiol Therapeutics Inc.LTM Mar 2026CA$11.4M CAD-21.5%+28.8%—
ALXOALX Oncology Holdings Inc.LTM Mar 2026$9.87M USD-60.9%-19.2%—
GUTSFractyl Health, Inc. Common StockLTM Mar 2026$7.81M USD-26.4%+28.7%—
HYPRHyperfine, Inc.LTM Mar 2026$2.5M USD-41.5%-35.9%16.3%
MBOTMicrobot Medical Inc.LTM Mar 2026$1.02M USD-11.2%-15.5%974.3%
HYFTMindWalk Holdings Corp.LTM Jan 2026CA$260K CAD-58.7%-47.5%1.4%
ZTEKZentek Ltd.LTM Mar 2026CA$190.87K CAD-64.5%—114.9%
BYSIBeyondSpring Inc.LTM Mar 2026$145K USD———
Peer median (excluding ZTEK) —-41.5%-19.2%11.7%

Competitors are the stored peer set for ZTEK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

CAD
Metric
FY2021
Mar 2022
FY2022
Mar 2023
FY2023
Mar 2024
FY2024
Mar 2025
FY2025
Mar 2026
Net Income(12.02M)(14.41M)(8.64M)(10.04M)(9.79M)
Depreciation & Amortization614.71K539.69K453.04K600.32K527.77K
Deferred Income Tax0(808.08K)000
Stock-Based Compensation4.73M3.2M01.53M0
Change in Working Capital(1.36M)(2.4M)675.37K1.48M1.5M
Accounts Receivables(536.82K)(12.84K)201.14K(906.22K)833.64K
Inventory(665.57K)(2.18M)(51.86K)397.48K168.74K
Accounts Payables831.48K000406.52K
Other Working Capital(985.52K)(198.98K)526.09K1.98M92.57K
Other Non-Cash Items48.12K917.7K1.57M150.99K2.68M
Operating Cash Flow(7.99M)(12.96M)(5.94M)(6.28M)(5.08M)
Capital Expenditures(3.99M)(2.27M)(236.3K)(1.4K)(2.03K)
Acquisitions (Net)007.38K02.38M
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities(3.27M)(33.64K)1.82M360.05K0
Investing Cash Flow(7.25M)(2.31M)1.39M358.65K1.67M
Debt Repayment(122.45K)(1.1M)(177.43K)(562.11K)1.63M
Common Stock Issued35.34M083.42K3.07M3.13M
Common Stock Repurchased00(301.82K)00
Dividends Paid00000
Other Financing Activities3.6M46K(95.42K)16.01K(172.43K)
Financing Cash Flow38.82M(1.05M)(491.25K)2.52M4.59M
Effect of Forex Changes005.31M04.08K
Net Change in Cash23.58M(16.32M)268.59K(3.4M)1.19M
Free Cash Flow(11.97M)(15.23M)(6.18M)(6.28M)(5.08M)

Zentek Ltd.

NASDAQ:ZTEK

Intrinsic Alpha fair value

Locked

Current Price

$0.49

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.